Correlation Between Sage Therapeutic and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sage Therapeutic and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sage Therapeutic and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sage Therapeutic and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Sage Therapeutic and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sage Therapeutic with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sage Therapeutic and Apellis Pharmaceuticals.
Diversification Opportunities for Sage Therapeutic and Apellis Pharmaceuticals
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sage and Apellis is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sage Therapeutic and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Sage Therapeutic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sage Therapeutic are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Sage Therapeutic i.e., Sage Therapeutic and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sage Therapeutic and Apellis Pharmaceuticals
Given the investment horizon of 90 days Sage Therapeutic is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Sage Therapeutic is 1.03 times more volatile than Apellis Pharmaceuticals. It trades about -0.09 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.26 per unit of volatility. If you would invest 2,726 in Apellis Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of 667.00 from holding Apellis Pharmaceuticals or generate 24.47% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sage Therapeutic vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Sage Therapeutic |
| Apellis Pharmaceuticals |
Sage Therapeutic and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sage Therapeutic and Apellis Pharmaceuticals
The main advantage of trading using opposite Sage Therapeutic and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sage Therapeutic position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Sage Therapeutic vs. Apellis Pharmaceuticals | Sage Therapeutic vs. Terns Pharmaceuticals | Sage Therapeutic vs. Day One Biopharmaceuticals | Sage Therapeutic vs. Blueprint Medicines Corp |
| Apellis Pharmaceuticals vs. Tff Pharmaceuticals | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |